Medpace Holdings, Inc. (MEDP) stock forecast and price target
Price $653.94 · data as of November 13, 2026
12-month price target
Gold marker: average target · white marker: today’s price ($653.94)
Analyst ratings
Earnings and revenue estimates
| Period | EPS estimate | EPS growth | Revenue estimate |
|---|---|---|---|
| Current fiscal year ends December 31, 2026 | $18.36 | +20.2% | $2.8B |
| Next fiscal year ends December 31, 2027 | $19.85 | +8.1% | $3.0B |
| Next quarter ends December 31, 2026 | $4.88 | +4.4% | $718M |
| Quarter after ends March 31, 2027 | $4.66 | +8.8% | $727M |
Consensus of the analysts covering Medpace, updated daily. In the last 30 days 10 estimates were raised and 0 lowered.
Our model vs. Wall Street
Analysts see 0.4% downside over 12 months. Our discounted cash flow model with moderate assumptions puts Medpace’s intrinsic value about 32% below today’s market value, and it scores 3.2 out of 5 on our checks. Price targets follow sentiment; a DCF follows cash. When both point the same way the signal is stronger. Try your own assumptions.
Frequently asked questions
What is the Medpace stock price target?
The average 12-month target from 13 analysts is $651.31, 0.4% below the current price of $653.94 Targets range from $370.00 to $730.00.
Is Medpace a buy according to analysts?
The consensus rating is “None” (1 strong buy, 1 buy, 11 hold, 1 sell). Ratings are opinions, not guarantees; this is not investment advice.
How much is Medpace expected to earn?
Analysts expect EPS of $18.36 for the fiscal year ending December 31, 2026 and $19.85 the year after.
Analyst consensus estimates and price targets, updated daily. Forecasts can be wrong; this is information, not investment advice.